FOSAMAX is indicated in adults for the treatment of postmenopausal osteoporosis. It reduces the risk of vertebral and hip fractures.
The FDA has approved Binosto (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of Osteoporosis in postmenopausal...
Alendronic acid is indicated in adults for the treatment of post-menopausal osteoporosis. Alendronic acid reduces the risk of vertebral and hip fractures.
The aim of the trial is to investigate the efficacy and safety of semaglutide once-weekly versus exenatide ER (extended release) 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes.
Amgen has announced results from the Phase III A.R.R.O.W. trial of a once-weekly Kyprolis (carfilzomib) dosing regimen in patients with...
Novo Nordisk announced that the FDA has issued a Refusal to File letter covering the label expansion application for once-weekly Ozempic (semaglutide 2.0 mg) for the treatment of type 2 diabetes which was filed on 20 January 2021.